Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: A journey revisited

Diagnostic Pathology

Volumn 4, Issue 1, 2009, Pages

  Kumar, Yashwant ^a   Bhatia, Alka ^b   Minz, Ranjana Walker ^b  

^a Department of Pathology and Laboratory Medicine   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62449341389     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-4-1     Document Type: Article

References (61)

1. Systemic diseases and the detection of nuclear and anticytoplasmic antibodies. A historical review. M Walravens, Clin Rheumatol 1987 6 9 17 10.1007/BF02200709 3304802
2. Pathology of disseminated lupus erythematosus. P Klemperer AD Pollack G Baehr, Arch Pathol (Chicago) 1941 32 569 631
3. Presentation of two bone marrow elements: the 'tart' cell and the "LE' cell. MM Hargraves H Richmond R Morton, Proceedings of the Mayo Clinic 1948 23 25 28
4. Complement fixation with cell nuclei and CNA in lupus erythematosus. WC Robbins HR Homan H Deicher HG Kunkel, Proceedings of the Society for Experimental Biology (New York) 1957 96 575
5. New serological methods for detection of LE factor. P Miescher R Strassle, Vox Sanguinis 1957 2 283 13496698
6. A DNA reacting factor in serum of a patient with lupus erythematosus. R Cepellini E Polli F Celeda, Proc Soc Exp Biol Med 1957 96 3 572 574 13505795
7. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. M Monestier BL Kotzin, Rheum Dis Clin North Am 1992 18 415 436 1626076
8. Antibodies to histones in systemic lupus erythematosus. E Fishbein D Alarcon-Segovia JM Vega, Clin Exp Immunol 1979 36 145 380854
9. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. EM Tan HG Kunke, J Immunol 1966 96 464 5932578
10. Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases. GL Asherson, Br J Exp Pathol 1959 40 209 13662525
11. An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. EM Tan, J Clin Invest 1967 46 735 4960935
12. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. GM Clark MTB Tomasi, J Immunol 1969 102 117 4179557
13. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. E Scopelitis JJ Biundo MA Alspaugh, Arthritis Rheum 1980 23 287 10.1002/art.1780230304 6965861
14. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen. M Matticli M Reichlin, Arthritis Rhum 1974 17 421 10.1002/art. 1780170413
15. Differentiation and characterization of autoantibodies and their antigens in Sjorgen's syndrome. MA Alspaugh N Talal EM Tan, Arthritis Rheum 1976 19 216 10.1002/art.1780190214 1259795
16. Antinuclear antibody with distinct specificity for polymyositis. JF Wolfe E Adelstein GC Sharp, J Clin Invest 1977 59 176 318657 10.1172/JCI108616
17. Diversity of antinuclear antibodies in progressive systemic sclerosis. EM Tan GP Rodnan I Garcia Y Moroi MJ Fritzler C Peebles, Arhtritis Rheum 1980 23 617 10.1002/art.1780230602
18. Laboratory testing in rheumatic diseases: a practical review. CL Colglazier PG Sutej, South Med J 2005 98 185 191 10.1097/01.SMJ.0000153572. 22346.E9 15759949
19. Serologic testing in connective tissue diseases. DE Habash-Bseiso HY Steven I Glurich JW Goldberg, Clin Med Res 2005 3 190 193 16160075
20. Identification and characterization of two new soluble nuclear antigens reactive with sera of patients with connective tissue disease. S Miyawaki K Kohmoto KN Ofuji, Arthritis Rheum 1978 21 803 810 10.1002/art.1780210711 358992
21. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. EM Tan, Adv Immunol 1989 44 93 151 10.1016/S0065- 2776(08)60641-0 2646863
22. Guidelines for the Laboratory Use of Autoantibody Tests in the Diagnosis and Monitoring of Autoimmune Rheumatic Diseases. R Tozzoli N Bizzaro E Tonutti D Villalta D Bassetti F Manoni A Piazza M Pradella P Rizzotti, Am J Clin Pathol 2002 117 316 324 10.1309/Y5VF-C3DM-L8XV-U053 11863229
23. Clinical application of lupus serum nucleoprotein reaction using fluorescent antibody technique. CJ Friou, J Clin Invest 1957 36 890 897
24. Guidelines for Clinical Use of the Antinuclear Antibody Test and Tests for Specific Auto antibodies to Nuclear Antigens. A Kavanaugh R Tomar J Reveille DH Solomon HA Homburger, Arch Pathol Lab Med 2000 124 71 81 10629135
25. Quality Assurance of Laboratory Tests for Autoantibodies to Nuclear Antigens: (1) Indirect Fluorescence Assay for Microscopy and (2) Microtiter Enzyme Immunoassay Methods; Approved Guideline-Second Edition. MM Lightfoote N Chirmule HA Homburger A Kavanaugh RM Nakamura W Papisch SY Tetin, CLSI 2006 26 13
26. New methods for detection of anti-nuclear antibodies. L Cook, Clin Immunopathol 1998 88 211 220 10.1006/clin.1998.4560
27. Molecular biology of nuclear antigens. MR Saitta JD Keene, Rheum Dis Clin North Am 1992 18 283 310 1626070
28. Antinuclear antibody testing in systemic autoimmune disease. J Evans, Clin Chest Med 1998 19 613 625 10.1016/S0272-5231(05)70106-4 9917956
29. Antinuclear antibodies by indirect immunofluorescence: Optimum screening dilution for diagnosis of systemic lupus erythematosus. P Ghosh S Dwivedi S Naik V Agarwal A Verma A Aggarwal R Misra, Indian J Med Res 2007 126 34 38 17890821
30. Occurrence of antinuclear antibodies in an unselected pregnancy population. J Kiuttu A Hartikainen R Makitalo, Gynecol Obstet Invest 1994 37 160 163 8005543
31. Antinuclear antibody determination in a routine laboratory. TE Feltkamp, Ann Rheum Dis 1996 55 723 727 8984936 10.1136/ard.55.10.723
32. E Greidinger R Hoffman, Antinuclear Antibody Testing: Methods, Indications, and Interpretation, CE Update Course in Laboratory Medicine 2003 34 113 118
33. Screening for antinuclear antibodies by enzyme immunoassay. TD Jaskowski C Schroder TB Martins CL Mouritsen CM Litwin HR Hill, Am J Clin Pathol 1996 105 468 473 8604689
34. The consensus workshops for the detection of auto antibodies to intracellular antigens in rheumatic diseases: 19891992. PJ Charles WJ van Venrooij RN Maini the Consensus Finding Group for Auto antibodies, Clin Exp Rheum 1992 10 507 511
35. Variability between methods to determine ANA, anti-dsDNA and anti-ENA auto antibodies: a collaborative study with the biomedical industry. N Bizzaro R Tozzoli E Tonutti A Piazza F Manoni A Ghirardello D Bassetti D Villalta M Pradella P Rizzotti, J Immunol Methods 1998 219 99 107 10.1016/S0022-1759(98) 00140-9 9831391
36. A practical guide for serologic evaluation of autoimmune connective tissue diseases. DF Mutasim BB Adams, J Am Acad Dermatol 2000 42 159 174 10.1016/S0190-9622(00)90121-X 10642668
37. Immunology of DNA III: Crithidia luciliae, a simple substrate for the determination of anti-ds-DNA with the immunofluorescent technique. LA Aarden ER de-Groot TEW Feltkamp, Proc N Y Acad Sci 1975 254 505 10.1111/j.1749-6632.1975. tb29197.x
38. The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus. NGP Slater JS Cameron MH Lessof, Clin Exp Immunol 1976 25 480 486 786521
39. A quantitative immunochemical measure of the primary interaction between IxBSA and antibody. RS Farr, J Infect Dis 1958 103 239 262 13611294
40. The LE cell and the LE serum factors. HR Holman HR Deicher HG Kunkel, Bull N Y Acad Med 1959 35 409 418 13662729
41. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. G Clark M Reichlin TB Tomasi, J Immunol 1969 102 107 122 5765450
42. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. EM Tan HG Kunkel, J Immunol 1966 96 464 471 5932578
43. Detection of antiextractable nuclear antigens in connective tissue diseases: comparison between passive haemagglutination, counterimmunoelectrophoresis and double immunodiffusion. A Siracusano M Agelli S Ioppolo, Ric Clin Lab 1985 15 33 38 3922039
44. Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein. G Boire FJ Lopez-Longo S Lapointe, Arthritis Rheum 1991 34 722 730 10.1002/art.1780340613 1711323
45. The consensus workshops for the detection of auto antibodies to intracellular antigens in rheumatic diseases. VWJ Venrooij P Charles RN Maini, J Immunol Methods 1991 140 181 189 10.1016/0022-1759(91)90369-Q 1906075
46. Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation? RJ Lock DJ Unworthy, J Clin Pathol 2001 54 187 190 11253128 10.1136/jcp.54.3.187
47. Evaluation of recombinant Ro/SSA, La/SSB, Sm and U1 RNP autoantigens in clinical diagnosis. JGG Lerma AZ Mendoza MJ Ramos, J Clin Lab Anal 1995 9 52 58 10.1002/jcla.1860090110 7722773
48. Simple Dot-Blot Method Evaluated for Detection of Antibodies against extractable Nuclear Antigens. AAM Ermens, Clin Chem 1997 43 2420 2422 9439465
49. Evaluation of a Novel Line-Blot Immunoassay for the Detection of Antibodies to Extractable Nuclear Antigens. J Damoiseaux K Boesten J Giesen J Austen JWC Tervaert, Ann NYA Sci 2006 1050 340 347 10.1196/annals.1313.036
50. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. SS Copple TB Martins C Masterson E Joly HR Hill, Ann N Y Acad Sci 2007 1109 464 472 10.1196/annals.1398.052 17785335
51. Evaluation of Multiplex Antinuclear Antibody Assay in Pediatric Patients. M Xu BB Roberts BA Busby RM Jack LS Finn HM Emery JC Rutledge, Lab Med 2007 38 671 675 10.1309/M18LWJLMUGRN4HEH
52. Determination of ANA specificity using the UltraPlex platform. J Smith D Onley C Garey, Ann N Y Acad Sci 2005 1050 286 294 10.1196/annals.1313.030 16014544
53. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. O Shovman B Gilburd Zandman-Goddard A Yehiely P Langevitz Y Shoenfeld, Autoimmunity 2005 38 105 109 10.1080/08916930400022707 15804711
54. Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients. E Bonilla L Francis F Allam M Ogrinc H Neupane PE Phillips A Perl, Clinical Immunology 2007 124 18 21 10.1016/j.clim.2007.04.010 17513177
55. Clinical Value of Multiplexed Bead-Based Immunoassays for Detection of Autoantibodies to Nuclear Antigens. EA Aghajani S Berzon A Sarkissian, Clin Vaccine Immunol 2007 40 505 509 10.1128/CVI.00034-07
56. Parallel Detection of Autoantibodies with Microarrays in Rheumatoid Diseases. Y Feng X Ke R Ma Y Chen G Hu F Liu, Clin Chem 2004 50 416 422 10.1373/clinchem.2003.023994 14670825
57. Clinical utility of common serum rheumatologic tests. SK Lane JW Gravel, Am Fam Physician 2002 65 1073 1080 11925083
58. Quantum dot bioconjugates for imaging, labeling and sensing. IL Medintz HT Uyeda ER Goldman H Mattoussi, Nature Mat 2005 4 435 446 10.1038/nmat1390
59. High-throughput multiantigen microfluidic fluorescence immunoassays. EP Kartalov JF Zhong A Scherer WF Anderson, BioTechniques 2006 40 85 90 10.2144/000112071 16454045
60. Autoantigen microarrays for multiplex characterization of autoantibody responses. WH Robinson C DiGennaro W Hueber BB Haab M Kamachi EJ Dean S Fournel D Fong MC Genovese, Nat Med 2002 8 1 7 10.1038/nm0302-295 11786879
61. Guidelines and Protocols Advisory Committee. BCGuidelines.ca 2007